
Oculomotor Biomarkers Recorded on 50 Patients with neuroClues®, now CE-Marked!
Learn more about neuroClues®’ role in the ICEBERG cohort with 50 patients recorded, and how eye movement analysis is advancing cognitive impairment detection.
Have a research question to share or an article to highlight?
A piece to write about neuroscience, eye tracking or neuroClues?
Let’s connect.
Learn more about neuroClues®’ role in the ICEBERG cohort with 50 patients recorded, and how eye movement analysis is advancing cognitive impairment detection.
Volgende stap: neuroClues op de Europese markt lanceren en de “stethoscoop van de hersenen” worden Samengevat neuroClues behaalt MDR-certificering (Medical Device Regulation) en mag
In summary neuroClues achieves Medical Device Regulation (MDR) certification and is now allowed to issue the CE-mark on its Class IIa medical device designed
Explore how neuroClues calculates the reference oculomotor ranges in eye tracking, with exclusive insights into the technical details.
Explore recent studies on how eye movements can support pharmaceutical research in diagnosing, monitoring, and developing new neurological treatments.
The newsletter of this month will emphasize the latest research about Multiple Sclerosis
The newsletter of this month will emphasize the latest research about Alzheimer’s Disease
The newsletter of this month will emphasize the latest research about Progressive Supra Nuclear Palsy (PSP) as May is PSP Awareness month
Objective: to become the “stethoscope of the brain”
The newsletter of this month will make you discover 3 recent articles highlighting the relevance of eye tracking for Concussion, Alzheimer’s disease and Parkinson’s disease.
neuroClues is powered by P3Lab SRL
VAT: BE 0750.746.841
Centre Monnet – Av. Jean Monnet, 1 –
1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France
Our development is financed with
the support of the Walloon Region and the European Innovation Council
© Neuroclues 2024 – all rights reserved
Book a custom virtual walk-through of NeuroClues with one of our experts and see how our innovative eye-tracking technology could impact your clinical practice.